FDA greenlights first vagus nerve device for arthritis relief
Image credit: towfiqu999999 via Unsplash
The FDA has approved the first vagus nerve stimulation device to treat rheumatoid arthritis, offering a new option for patients who don’t respond well to traditional medications. The implant works by sending mild electrical pulses to the vagus nerve, which helps reduce inflammation and ease joint pain. This marks a significant step forward in using bioelectronic medicine to manage chronic autoimmune diseases.
Source
Geert D’Haens et al. Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn’s Disease Patients: A Prospective Open-label Study, Journal of Crohn's and Colitis, Volume 17, Issue 12, December 2023, Pages 1897–1909, https://doi.org/10.1093/ecco-jcc/jjad151
Additional Reading